Locations:
SearchAdvertisement
Single-cell next-gen sequencing showing promise to improve sensitivity of MRD testing
Study assesses the impact of donor source and post-transplant prophylaxis for patients receiving a hematopoietic cell transplant
Prior history of autoimmunity and solid organ transplantation significantly increases chance of myelodysplastic syndrome or acute myeloid leukemia
Research aims to find a biomarker for early detection and intervention
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
May not translate to better outcomes
A major advance in prognosis for myelodysplastic syndromes that may improve outcomes
Encouraging clinical efficacy with no rise in adverse events
Luspatercept shows promise for patients with few options
Preliminary results from a national registry
CHIP clinic in the works
Advertisement
Advertisement